Efferent Labs 43North Video Pitch
https://youtu.be/hdfwZ0FUpXA
Implantable Biosensor Developed at URMC
A new device created at the University of Rochester could provide physicians with real time information about the health of their patients.
Implantable Diagnostic Technology Advances
Raland’s CytoComm™ technology has been issued another patent.
Path To 43North
Raland Therapeutics featured in Democrat & Chronicle headline news article.
Efferent Labs named as finalist in 43North Business Competition
Raland Therapeutics is a finalist in the $5M 43North competition.
43North Business Competition Finalists Announced
Raland Therapeutics is one of the eleven finalists in a worldwide business competition